1. Home
  2. CMPX vs BFS Comparison

CMPX vs BFS Comparison

Compare CMPX & BFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

N/A

Current Price

$5.77

Market Cap

926.7M

Sector

Health Care

ML Signal

N/A

BFS

Saul Centers Inc.

N/A

Current Price

$34.26

Market Cap

770.9M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
CMPX
BFS
Founded
2014
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
926.7M
770.9M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
CMPX
BFS
Price
$5.77
$34.26
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
$14.43
N/A
AVG Volume (30 Days)
1.8M
56.8K
Earning Date
03-31-2026
01-01-0001
Dividend Yield
N/A
6.88%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$850,000.00
N/A
Revenue This Year
N/A
$8.14
Revenue Next Year
N/A
$5.75
P/E Ratio
N/A
$30.48
Revenue Growth
N/A
N/A
52 Week Low
$1.33
$29.16
52 Week High
$6.88
$37.89

Technical Indicators

Market Signals
Indicator
CMPX
BFS
Relative Strength Index (RSI) 43.18 58.94
Support Level $4.78 $31.18
Resistance Level $5.86 $35.18
Average True Range (ATR) 0.31 0.63
MACD -0.11 -0.07
Stochastic Oscillator 6.54 52.22

Price Performance

Historical Comparison
CMPX
BFS

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

About BFS Saul Centers Inc.

Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: shopping centers, which contribute the maximum portion of total revenue; and mixed-use properties. Maximum tenants include grocery stores, discount department stores, and drug stores.

Share on Social Networks: